Digitisation | October 25, 2023
Nanoform grant global starmap AI license to AstraZeneca
Nanoform will receive access to compound libraries and large data sets to undertake STARMAP screening
Nanoform will receive access to compound libraries and large data sets to undertake STARMAP screening
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
Tagrisso is projected to be a pivotal contributor to AstraZeneca’s portfolio
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
Good momentum in commercial CDMO business
Subscribe To Our Newsletter & Stay Updated
